Numinus Wellness Inc. Announces First Quarter Fiscal 2025 Results
All financial results are reported in Canadian dollars unless otherwise stated.Vancouver, British Columbia--(Newsfile Corp. - August 8, 2025) - Numinus...
Year: 2025
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2026 Financial Results on August 15, 2025
Financials for First Quarter of Fiscal Year 2026 Ended June 30, 2025 will be released on Thursday, August 14, 2025Northvale,...
Escalating Tariffs and Global Drug-Pricing Mandates Reshape Q3 2025 Healthcare IT Investment Strategies
Black Book Research Survey Finds Trade Policy Shifts, MFN Enforcement, and Supply Chain Vulnerabilities Driving a High-Stakes Reset in Digital...
MarketsandMarkets’ 360Quadrants Recognizes Top Startups and SMEs in the Hospital Information System Quadrant Report 2025
DELRAY BEACH, Fla., Aug. 8, 2025 /PRNewswire/ -- 360Quadrants has released its latest Hospital Information System Startups/SMEs, 2025, recognizing key...
Elevating Patient Care: Senderra Specialty Pharmacy Adds EBGLYSS™ (lebrikizumab-lbkz), Lilly’s First-Line Biologic Treatment for Moderate-to-Severe Atopic Dermatitis, to SenderraCare+ for a Streamlined, Empowering Digital Patient Experience
SenderraCare+ redefines specialty therapy by consolidating enrollment, adherence support, and medication management into one intuitive, in real-time digital platform. It...
The Total Value of Medical Devices Imported Into The Association of Southeast Asian Nations (ASEAN) Exceeded $19 Billion Globally in 2024
JERSEY CITY, N.J., Aug. 8, 2025 /PRNewswire/ -- According to the latest study from Pure Global, ASEAN MedTech Market Report:...
RBL LLC secures investment from Modi Ventures
- Strategic investment to support RBL's mission to launch and scale breakthrough startups - Founder and general partner of Modi...
Aqua Sculpt Reviews (SHOCKING REPORT 2025) What You Must Know Before Trying AquaSculpt for Weight Loss
SAN DIEGO, CA / ACCESS Newswire / August 8, 2025 / If you've been catching chatter about an "ice water...
Is Audifort a Scam or the Real Natural Fix for Tinnitus and Hearing Loss? Latest Audifort Reviews Inside
CHICAGO, IL / ACCESS Newswire / August 8, 2025 / If that constant ringing in your ears is starting to...
Silo Wellness Appoints Defense Finance Veteran Richard Craven as CEO to Guide Strategic Transition to Born Defense
Eugene, Oregon and Toronto, Ontario--(Newsfile Corp. - August 8, 2025) - Silo Wellness Inc. (CSE: SILO) ("Silo," or the "Company")...
MDCE Powers Up with Patent-Pending AI Tech, Auction Expansion & Share Restructure Plan
Game-Worn Icons. AI Innovation. Big Restructure. MDCE Is On a Mission. MESA, ARIZONA / ACCESS Newswire / August 8, 2025...
Modular Medical Announces Next-Generation Pivot Insulin Pump at ADCES and Introduction of Level Ex Gamified Training Collaboration
-Debuting a "coming soon" campaign for tubeless Pivot patch pump- Expects special 510(k) filing for Pivot product in October- Will...
Enovis to Participate in Upcoming Investor Conferences
Wilmington, DE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced...
Ultrack Systems Inc. (OTC: MJLB) Adds PUR Botanicals as Strategic Partner in PUR Rx Joint Venture: A Fully Vertically Integrated Natural Health Pharmacy Targeting Explosive Growth
TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB), a Canadian-based leader in wellness-focused technology and compliance-driven...
Capricor Therapeutics Announces Type A Meeting Scheduled with U.S. FDA
– Second Quarter 2025 Financial Results and Corporate Update Rescheduled to Monday, August 11, 2025, at 4:30 p.m. ET –SAN...
Assembly Biosciences Announces Pricing of $175 Million in Equity Financings
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (“Assembly Bio”) (Nasdaq: ASMB), a biotechnology company...
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-- Completed patient enrollment in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED); topline data expected...
Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a...
CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates
- Announced best-in-disease durability data in BOND-003 Cohort C and promising early signal in Cohort P for cretostimogene grenadenorepvec at...
Vaxart CEO Issues Letter to Stockholders
- Management Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on September 4, 2025...